The drug combination trimethoprim/polymyxin (INNs, trade name Polytrim) is an antimicrobial solution for topical ophthalmic[1] use in the treatment of acute bacterial conjunctivitis and blepharoconjunctivitis.[citation needed]
| Combination of | |
|---|---|
| Trimethoprim | Nucleic acid inhibitor antibiotic |
| Polymyxin | Cell envelope antibiotic |
| Clinical data | |
| Other names | Polymyxin B sulfate and trimethoprim sulfate |
| Routes of administration | Eye drops |
| ATC code | |
| Legal status | |
| Legal status |
|
| Identifiers | |
| CAS Number | |
| PubChem CID | |
| KEGG | |
| CompTox Dashboard (EPA) | |
| (verify) | |
References
edit- ^ "Polytrim - FDA prescribing information, side effects and uses". Drugs.com. Retrieved 6 April 2021.
 | This pharmacology-related article is a stub. You can help Wikipedia by expanding it. |